← All indications
Disease Progression
The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Subtype terms (3)
More specific conditions that are subtypes of Disease Progression in the MeSH hierarchy.
Drugs by status
Phase 4 trials (5)
Phase 3 trials (1)
Phase 2 trials (19)
Phase 1 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (37)
- Roche
- Clinvest
- GlaxoSmithKline
- Kobe University
- Mundipharma
- Qidong Gaitianli Medicines Co., Ltd
- Fundacion Investigacion y Desarrollo
- Region Syddanmark
- Huazhong University of Science and Technology
- Aarhus University
- Pauls Stradins Clinical University Hospital
- Seoul National University
- The Baruch Padeh Medical Center, Poriya
- Universidad Autonoma de Madrid
- Universidad Complutense de Madrid
- University of Southern Denmark
- University of Sydney
- Mayo Clinic
- University of Copenhagen
- University of Ulsan
- CJ HealthCare Corp.
- University of Munster
- Jiao Tong University
- National Taiwan University
- University of Lyon
- University of Barcelona
- Innovative Medical Research of South Florida, Inc
- Lakeside Eye Clinic
- Royal College of General Practitioners
- University of New South Wales
- +7 more
Organization Involved with Phase 3 Indications (35)
- Eisai
- Millennium Pharmaceuticals
- AstraZeneca
- Merck
- Octapharma
- Aventis
- Alnylam Pharmaceuticals
- Baxalta
- Teva
- Boehringer Ingelheim
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Roma La Sapienza
- Cancer Research UK
- Harvard University
- German CLL Study Group
- Phoenix Molecular Imaging
- Qingdao Central Hospital
- University of Heidelberg
- University of Malaya
- University of Ottawa
- Capital Medical University
- University of Colorado, Denver
- University of Monastir
- University of Toulouse
- Hospital Alessandro Manzoni Lecco
- Universita' Cattolica del Sacro Cuore
- Government of Pakistan
- Janssen Pharmaceutica NV
- University of Sao Paulo
- +5 more
Organization Involved with Phase 2 Indications (85)
- Regeneron
- Vertex
- Imclone
- Eli Lilly
- Genentech
- Sanofi
- Avanir
- AIO-Studien-gGmbH
- Novartis
- Bayer
- Camel-IDS NV
- Hengrui Therapeutics, Inc.
- ISA Pharmaceuticals
- Oncolys BioPharma Inc
- Shanghai Henlius Biotech
- Pulmotect, Inc.
- Shanghai Junshi Bioscience Co.,Ltd.
- TG Therapeutics, Inc.
- Fondazione Neoplasie Sangue Onlus
- National Cancer Institute (NCI)
- National Cancer Institute, France
- National Institute of Allergy and Infectious Diseases (NIAID)
- Academic and Community Cancer Research United
- Centre Leon Berard
- Chang Gung University
- Cornell University
- Duke University
- Finnish Lung Cancer Group
- Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
- Julius-Maximilians University
- +55 more
Organization Involved with Phase 1 Indications (19)
- AbbVie
- Takeda
- Pharmacyclics
- Biogen
- Array BioPharma
- Syntrix Biosystems, Inc.
- Michael J. Fox Foundation for Parkinson's Research
- National Heart, Lung, and Blood Institute (NHLBI)
- Hackensack Meridian Health
- Institut fur Klinische Forschung, Germany
- Istituto Nazionale per lo Studio e la Cura dei Tumori
- Rutgers University
- University of South Florida
- Tel Aviv University
- University of California, San Diego
- University of California, San Francisco
- Technion University
- Washington University in St. Louis
- Cellex Patient Treatment GmbH
Organization Involved with Other Experimental Indications (20)
- PPD
- Centocor
- Merck KGaA
- National Institute of Neurological Disorders and Stroke (NINDS)
- Cantonal Hosptal, Baselland
- University of London
- University of Washington
- Ifakara Health Institute
- Kenya Medical Research Institute
- University of Florida
- University of Bern
- Institute of Liver and Biliary Sciences, India
- Kwame Nkrumah University of Science and Technology
- Noguchi Memorial Institute for Medical Research
- University of Basel
- Southern Medical University
- University of Montpellier
- University of Turin
- Ruhr University Bochum
- Centers for Disease Control and Prevention (CDC)